ARES vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

ARES

52.8
AI Score
VS
IVZ Wins

IVZ

50.9
AI Score

Investment Advisor Scores

ARES

53score
Recommendation
HOLD

IVZ

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ARES IVZ Winner
Forward P/E 21.5054 10.395 IVZ
PEG Ratio 1.2101 0.9008 IVZ
Revenue Growth 5.8% 20.5% IVZ
Earnings Growth 6.5% 35.0% IVZ
Tradestie Score 52.8/100 50.9/100 ARES
Profit Margin 10.6% -0.9% ARES
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ARES 1M: +18.5% · 3M: +16.4% IVZ 1M: +14.4% · 3M: +19.4%

Current Technical Phase

ARES

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.1% over 20 days), RSI 69

RSI (14): 69.4 · Price: $138.57

IVZ

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.8% over 20 days), RSI 62

RSI (14): 61.5 · Price: $30.91

Fundamentals Snapshot

Metric ARES IVZ
Market Cap
Forward P/E 19.2 9.2
Trailing P/E 59.3
Revenue (TTM)
Revenue Growth 0.1% 0.2%
Gross Margin 0.4% 0.3%
Operating Margin 0.2% 0.2%
EPS 2.16 -1.40
Dividend Yield 0.04% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.